UPDATE: JPMorgan Downgrades Medtronic, Inc. (MDT) to Neutral, Removes from Analyst Focus List

Medtronic announces two executive committee changes

DUBLIN, Dec. 16, 2021 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, made two announcements today regarding its executive committee. Ivan Fong has been named as general counsel and secretary, succeeding Brad Lerman, who will retire at the end of January. In addition, the company also announced that Rick Kuntz, M.D., M.Sc., chief medical officer and chief scientific officer, has announced his intention to retire in April, at the end of the Medtronic... More

Virtua Health and Medtronic Share Plans to Reimagine Traditional Health Care Models

MARLTON, N.J., Dec. 15, 2021 /PRNewswire/ -- Virtua Health and Medtronic plc (NYSE: MDT) announce a five-year partnership focused on improving delivery of quality care for residents of South Jersey, particularly those who reside in underserved communities or face systemic barriers to care. Medtronic LABS, an independent impact-focused organization funded by Medtronic plc, will simultaneously launch a separate pilot collaboration with the Cherry Hill Free Clinic and Virtua to address care and food access for people with chronic conditions the first U.S.-based initiative for Medtronic LABS. 

"I truly... More

Medtronic Diabetes receives FDA warning letter

DUBLIN, Dec. 15, 2021 /PRNewswire/ -- Medtronic plc (NYSE: MDT) today announced it received a warning letter from the U.S. Food and Drug Administration (FDA) on December 9 for the company's Northridge, California, facility, the headquarters for its... More

Medtronic Diabetes receives FDA warning letter

DUBLIN, Dec. 15, 2021 /PRNewswire/ -- Medtronic plc (NYSE: MDT) today announced it received a warning letter from the U.S. Food and Drug Administration (FDA) on December 9 for the company's Northridge, California, facility, the headquarters for its... More